A fascinating post from Richard Williamson about far-UVC, a technique that uses ultraviolet light to kill pathogens in the air without harming people or other organisms:
“One of the best shots we have at turning the page on airborne disease is an emerging type of germicidal UV (GUV) light called far-UVC. Over the last decade, researchers have documented its ability to eliminate pathogens while being safe for humans. A landmark study from 2022 found that far-UVC reduced the concentrations of airborne bacteria by 98.4 percent in a room-sized chamber, all while operating within safe UV exposure limits. Compared to standard ventilation, this was the equivalent of changing the air completely over in the room 184 times every hour. To put that in perspective, the CDC recommends 5 or more air changes per hour in the workplace. Even hospital operating rooms in the US only require 20. Far-UVC is effective against viruses too; airborne coronaviruses are more susceptible to far-UVC than the same bacteria used in the other study.”
If it’s so simple, why hasn’t it been adopted yet? Richard argues that the problem is partly regulatory: there is no straightforward approval pathway for a device like this, like there would be if it were a drug. That means that people can just implement it (good) but also that there’s no rigorous trial process that proves its efficacy (bad). Without that proof, large institutions are unlikely to invest in a rollout of something that might be hokum.
Why doesn’t someone pay for a rigorous trial, then? The other problem is that UVC isn’t patentable (it’s already generic, there’s lots of prior art), so if a manufacturer made the huge investment in proving UVC’s efficacy then its competitors would be able to free-ride off the back of its work.
This is one of those posts where I have a slight amount of epistemic learned helplessness; I don’t know enough about the science to know if the bold claims of efficacy are true, or if there are unforeseen consequences or side-effects lurking here. But there’s something interesting in Richard’s proposed solution, which is to set up a non-profit to validate the claims so that everyone can benefit. I wonder what other inventions and breakthroughs have this same shape of coordination problem preventing their widepsread adoption? #